Real-time enrollment status for this multiple myeloma clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 12:06 PM UTC
| NCT Number | NCT06169215 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Multiple Myeloma |
| Phase | Clinical Trial |
| Target Enrollment | 70 participants |
| Active Locations | 27 sites in the US |
| Sponsor | National Cancer Institute (NCI) |
| Last Updated on CT.gov | February 27, 2026 (3 days ago) |
As of March 2, 2026: Clinical trial NCT06169215 is currently active_not_recruiting participants. This clinical trial study for multiple myeloma is not currently accepting new participants at 27 locations across the United States. The study is sponsored by National Cancer Institute (NCI). This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06169215 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 27 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06169215 was last updated 3 days ago (February 27, 2026). HelloStudys verifies this status automatically.